Funding
EPFL Innogrant · Healthtech

Infera Neuro receives CHF100,000 EPFL Innogrant

The Swiss neural-chip team will complete its prototype and validate its brain-interface technology.

By RoundOS Funding desk

Infera Neuro received a CHF100,000 EPFL Innogrant, announced on December 15, 2025. The university programme award, sponsored by UBS, will support prototype completion and validation.

The company develops low-power neural-interface chips with AI decoding on the device. Its work aims to reduce the power, heat and communication demands of brain-computer interfaces and neuromodulation systems.

Use of funds

Complete the neural-chip prototype and validate its approach.

Funding history

EPFL Innogrant · This roundCHF 100K

Sources

  1. EPFL startup grant award announcementactu.epfl.ch · Dec 15, 2025
  2. infera-neuro.com

Similar rounds

All Healthtech rounds →
LIFESCAPES

Japanese developer of brain-machine interface rehabilitation devices for people with impaired hand movement.

UndisclosedFollow-on equity investment · Oct 30, 2026
Jagruti Rehabilitation Centre

Jagruti Rehabilitation Centre operates residential facilities for mental healthcare, addiction treatment and dementia care across India.

₹280MSeries A · Oct 29, 2026
Docterz

Docterz provides clinic software for patient records, appointments, billing, vaccination management and communication between doctors and patients.

₹50MUndisclosed · Oct 29, 2026
Magic Vision

Magic Vision develops AI monitoring technology that helps care providers and families respond to falls and changes in daily activity.

€600KFunding round · Oct 28, 2026

Related